AUSSENDER



CO.DON AG
Ansprechpartner: Matthias Meißner
Tel.: +49 341 99190330
E-Mail: ir@codon.de
Pressefach (105)

Rechtsgrundlage

Alle
Insiderinformationen
Unternehmensmitteilungen
Finanzberichte
Stimmrechtsmitteilungen
HV-Bekanntmachungen
Sonstige

Schlagwörter

Unternehmen
Beteiligungsmeldung
CO.DON AG
DE EN
01.11.2022 - 10:00 | CO.DON AG
5-year results of phase III clinical trial published
26.07.2022 - 12:39 | CO.DON AG
Application for opening of insolvency proceedings
05.05.2022 - 10:00 | CO.DON AG
European Commission grants indefinite renewal of EU-wide marketing authorization for the pharmaceutical product Spherox
29.04.2022 - 15:45 | CO.DON AG
CO.DON AG: Chairman of the Supervisory Board resigns for health reasons
28.03.2022 - 10:00 | CO.DON AG
Spherox included on the list of pharmaceutical products reimbursed in Belgium
21.03.2022 - 10:00 | CO.DON AG
CO.DON AG and JOINT OPERATIONS (UK) LLP sign contract for the distribution of Spherox in United Kingdom
01.03.2022 - 10:45 | CO.DON AG
Recommendation to make EU marketing authorisation for Spherox valid for an unlimited period
25.02.2022 - 14:26 | CO.DON AG
Member of the Management Board resigns as of February 28, 2022
25.01.2022 - 12:00 | CO.DON AG
5-year results confirm safety and effectiveness of M-ACT with spheroids
08.12.2021 - 12:19 | CO.DON AG
Mexico's ambassador visits CO.DON AG
06.12.2021 - 10:38 | CO.DON AG
licence agreement for product out-licensing in the Asian economic area signed
17.08.2021 - 10:21 | CO.DON AG
CO.DON AG: Start of routine production at the Leipzig site on time and on budget
07.06.2021 - 10:00 | CO.DON AG
GMP inspection of the higher fed authority and the Saxony state directorate at the Leipzig site successfully completed
03.06.2021 - 10:00 | CO.DON AG
Marketing authorisation granted for Spherox in the United Kingdom
25.05.2021 - 10:00 | CO.DON AG
EU-approved medicinal product receives vote for indication extension for use in adolescents
|
99.101 Abonnenten
|
235.014 Meldungen
|
95.157 Pressefotos
|
Folgen Sie uns auf Twitter
|
Persönlicher Kontakt